Michael Klowden - 29 Sep 2023 Form 3 Insider Report for NKGen Biotech, Inc. (NKGN)

Role: Director
Signature: /s/ Pierre Gagnon, Attorney-in-fact
Issuer symbol: NKGN
Transactions as of: 29 Sep 2023
Net transactions value: $0
Form type: 3
Filing time: 10 Oct 2023, 16:15:42 UTC
Next filing: 14 Feb 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

See attached Exhibit 24 - Power of Attorney